| Lorinda Arechy, CCC-SLP | |
|
758 Kapahulu Ave Ste 100-1099, Honolulu, HI 96816-1196 | |
| (707) 980-3310 | |
| Not Available |
| Full Name | Lorinda Arechy |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 758 Kapahulu Ave Ste 100-1099, Honolulu, Hawaii |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1053093310 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | SP-1815 (Hawaii) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Lorinda Arechy, CCC-SLP 758 Kapahulu Ave, Ste 100, #1099, Honolulu, HI 96816 Ph: () - | Lorinda Arechy, CCC-SLP 758 Kapahulu Ave Ste 100-1099, Honolulu, HI 96816-1196 Ph: (707) 980-3310 |
News Archive
Mount Sinai Medical Center in Miami Beach, Florida announced its participation in the Medtronic CoreValve U.S. Clinical Trial, which will evaluate a new, non-surgical alternative to open-heart surgery for patients with severe aortic stenosis. Mount Sinai is now among a select number of leading hospitals across the U.S. to participate in this trial.
Today, Insilico Medicine, Inc., a company applying the latest advances in deep learning to biomarker development, drug discovery and aging research, launched ALS.AI, a personalized drug discovery and biomarker development platform utilizing the latest advances in deep learning.
Heart disease remains the number one cause of early disability and death in the western world and now, surprisingly, has also become the most frequent cause of early death in the developing world.
In many pharmaceutical company and university laboratories, scientists are looking closely at kinase complexes because the enzymes play key roles in essential cell functions. By taking unusual steps to examine a kinase complex, researchers at Brown University and the National Institutes of Health have found a sought-after prize: an unprecedentedly detailed description of its structure complete with a rare location on its structure that could be a target for new therapeutic drugs.
MICARDIS(R) (telmisartan) has received Health Canada approval to reduce the risk of non-fatal stroke or non-fatal myocardial infarction in patients 55 years or older at high risk of developing major cardiovascular events who cannot tolerate an angiotensin converting enzyme (ACE) inhibitor.
› Verified 3 days ago
Lauren Marie Eudoxie, M.SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 725 Kapiolani Blvd, Honolulu, HI 96813 Phone: 808-596-4650 | |
Jacquelyn Jarachovic, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1519 Queen Emma St, Honolulu, HI 96813 Phone: 808-587-4510 | |
Shauna Ainuu, M.S. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 710 Green St, Honolulu, HI 96813 Phone: 808-536-3764 | |
Maria Jordan, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 475 22nd Ave Rm 127, Honolulu, HI 96816 Phone: 808-733-4940 | |
Tina Thanh Huong Le, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 475 22nd Ave # 302, Honolulu, HI 96816 Phone: 808-305-9750 Fax: 808-733-9154 | |
Marissa Lyn Cheape, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 475 22nd Ave Rm 127, Honolulu, HI 96816 Phone: 808-627-7300 | |
Mrs. Christie Eiko Hoota Iraha, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 475 22nd Ave Rm 127, Honolulu, HI 96816 Phone: 808-282-2333 |